Table 4.
N | % β-Blocker | None (0) | Partial (1) | Nonspecific (2) | Specific (3) | Spearman(Sig) | |
---|---|---|---|---|---|---|---|
Phase 1 | 21 | 81% | 88% of 16 | 60% of 5 | −0.30 (p=0.19) | ||
Phase 2 | 37 | 68% | 68% of 22 | 70% of 10 | 60% of 5 | −0.03 (p=0.86) | |
Phase 3 | 26 | 69% | 33% of 6 | 88% of 8 | 100% of 1 | 73% of 11 | 0.24 (p=0.23) |
Phase 4 | 26 | 77% | 67% of 3 | 43% of 7 | 80% of 5 | 100% of 11 | 0.49 (p=0.01) |